Friday, October 1, 2021
A new antiviral drug, molnupiravir, prevented half of severe COVID-19 infections, a study found
A new antiviral drug, molnupiravir, prevented half of severe COVID-19 infections, a study found: An experimental drug prevented half of COVID-19 infections that would otherwise have sent people to the hospital, according to a study released Friday
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment